5,8,11,14-Eicosatetraenamide, N-[2-(5-hydroxy-1H-indol-3-yl)ethyl]-,(5Z,8Z,11Z,14Z)-


Chemical Name: 5,8,11,14-Eicosatetraenamide, N-[2-(5-hydroxy-1H-indol-3-yl)ethyl]-,(5Z,8Z,11Z,14Z)-
CAS Number: 187947-37-1
Product Number: AG002GLA(AGN-PC-0QH0WT)
Synonyms:
MDL No: MFCD02179189
Molecular Formula: C30H42N2O2
Molecular Weight: 462.6667

Identification/Properties


Computed Properties
Molecular Weight:
462.678g/mol
XLogP3:
7
Hydrogen Bond Donor Count:
3
Hydrogen Bond Acceptor Count:
2
Rotatable Bond Count:
17
Exact Mass:
462.325g/mol
Monoisotopic Mass:
462.325g/mol
Topological Polar Surface Area:
65.1A^2
Heavy Atom Count:
34
Formal Charge:
0
Complexity:
652
Isotope Atom Count:
0
Defined Atom Stereocenter Count:
0
Undefined Atom Stereocenter Count:
0
Defined Bond Stereocenter Count:
4
Undefined Bond Stereocenter Count:
0
Covalently-Bonded Unit Count:
1
Compound Is Canonicalized:
Yes

Safety Information


NMR Spectrum


Other Analytical Data


Request for Quotation


Customer Feedback


Chemical Structure



The compound (5Z,8Z,11Z,14Z)-N-[2-(5-Hydroxy-1H-indol-3-yl)ethyl]-5,8,11,14-eicosatetraenamide is commonly utilized in chemical synthesis as a key intermediate in the production of various pharmaceuticals and bioactive molecules. Its unique structure, containing a long-chain eicosatetraenamide backbone and an indole functional group, allows for versatile synthetic pathways in drug discovery and development. Specifically, this compound serves as a crucial building block for the synthesis of novel anti-inflammatory agents, lipid mediators, and cannabinoid receptor modulators. By utilizing (5Z,8Z,11Z,14Z)-N-[2-(5-Hydroxy-1H-indol-3-yl)ethyl]-5,8,11,14-eicosatetraenamide in chemical reactions, researchers can access diverse chemical derivatives with potential therapeutic applications in various disease states.